School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

DAXOR CORP DXR

Healthcare · Medical Instruments & Supplies

$10.41last close 2026-10-09 · market cap $60.78M · delayed data

Trailing returns

1M-4.06%
3M+2.97%
6M+10.74%
1Y-18.22%
5Y-7.14%

Basis: Adjusted daily closes.

What it does

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973.

Open DXR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies